 |
Adaptimmune Therapeutics plc
ADAP
|
25 |
- |
-15.15 % |
$ 60.3 M |
Britain |
 |
Adverum Biotechnologies
ADVM
|
222 |
- |
- |
$ 86.2 M |
USA |
 |
ANI Pharmaceuticals
ANIP
|
114 |
$ 80.34 |
- |
$ 1.55 B |
USA |
 |
Acasti Pharma
ACST
|
1.97 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Aptorum Group Limited
APM
|
20.6 |
$ 0.84 |
1.96 % |
$ 4.58 M |
China |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
Adagene
ADAG
|
53.8 |
$ 2.67 |
- |
$ 150 M |
China |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K |
$ 3.57 |
- |
$ 8.59 B |
Australia |
 |
Acorda Therapeutics
ACOR
|
48.3 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
74.6 |
$ 1.5 |
- |
$ 281 M |
USA |
 |
Albireo Pharma
ALBO
|
14.7 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Ascendis Pharma A/S
ASND
|
132 |
$ 222.03 |
- |
$ 5 B |
Danmark |
 |
Aptinyx
APTX
|
46.9 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aravive
ARAV
|
16.8 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Arena Pharmaceuticals
ARNA
|
946 |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
Aridis Pharmaceuticals
ARDS
|
59 |
- |
17.91 % |
$ 11.1 M |
USA |
 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
78.4 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Athersys
ATHX
|
22.6 |
- |
3.77 % |
$ 22.4 M |
USA |
 |
Compugen Ltd.
CGEN
|
60.8 |
$ 1.71 |
- |
$ 153 M |
Israel |
 |
Amneal Pharmaceuticals
AMRX
|
55.7 |
$ 14.52 |
- |
$ 4.49 B |
USA |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
CureVac N.V.
CVAC
|
13.6 |
- |
- |
$ 867 M |
Germany |
 |
Alpine Immune Sciences
ALPN
|
154 |
- |
- |
$ 2.17 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |